576 related articles for article (PubMed ID: 15545514)
1. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
[TBL] [Abstract][Full Text] [Related]
2. Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice.
Park TS; Rosebury W; Kindt EK; Kowala MC; Panek RL
Pharmacol Res; 2008 Jul; 58(1):45-51. PubMed ID: 18611440
[TBL] [Abstract][Full Text] [Related]
3. Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice.
Park TS; Panek RL; Rekhter MD; Mueller SB; Rosebury WS; Robertson A; Hanselman JC; Kindt E; Homan R; Karathanasis SK
Atherosclerosis; 2006 Dec; 189(2):264-72. PubMed ID: 16458317
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration.
Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye KA; Stocker R; Jessup W; Garner B
Biochem Pharmacol; 2007 May; 73(9):1340-6. PubMed ID: 17239824
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipids and atherosclerosis: a mechanistic connection? A therapeutic opportunity?
Tabas I
Circulation; 2004 Nov; 110(22):3400-1. PubMed ID: 15569847
[No Abstract] [Full Text] [Related]
6. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes.
Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE
Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699
[TBL] [Abstract][Full Text] [Related]
7. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
[TBL] [Abstract][Full Text] [Related]
8. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment.
Johnson J; Carson K; Williams H; Karanam S; Newby A; Angelini G; George S; Jackson C
Circulation; 2005 Mar; 111(11):1422-30. PubMed ID: 15781753
[TBL] [Abstract][Full Text] [Related]
9. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
11. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
12. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models.
Reddy ST; Nguyen JT; Grijalva V; Hough G; Hama S; Navab M; Fogelman AM
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1676-81. PubMed ID: 15242861
[TBL] [Abstract][Full Text] [Related]
13. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis.
Schieffer B; Selle T; Hilfiker A; Hilfiker-Kleiner D; Grote K; Tietge UJ; Trautwein C; Luchtefeld M; Schmittkamp C; Heeneman S; Daemen MJ; Drexler H
Circulation; 2004 Nov; 110(22):3493-500. PubMed ID: 15557373
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E*3-Leiden transgenic mice as a test model for hypolipidaemic drugs.
van Vlijmen BJ; Pearce NJ; Bergö M; Staels B; Yates JW; Gribble AD; Bond BC; Hofker MH; Havekes LM; Groot PH
Arzneimittelforschung; 1998 Apr; 48(4):396-402. PubMed ID: 9608883
[TBL] [Abstract][Full Text] [Related]
15. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice.
Alp NJ; McAteer MA; Khoo J; Choudhury RP; Channon KM
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):445-50. PubMed ID: 14707037
[TBL] [Abstract][Full Text] [Related]
16. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
[TBL] [Abstract][Full Text] [Related]
17. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
18. Disodium ascorbyl phytostanyl phosphate reduces plasma cholesterol concentrations and atherosclerotic lesion formation in apolipoprotein E-deficient mice.
Lukic T; Wasan KM; Zamfir D; Moghadasian MH; Pritchard PH
Metabolism; 2003 Apr; 52(4):425-31. PubMed ID: 12701053
[TBL] [Abstract][Full Text] [Related]
19. A gastrointestinal lipase inhibitor reduces progression of atherosclerosis in mice fed a western-type diet.
Ueshima K; Akihisa-Umeno H; Nagayoshi A; Takakura S; Matsuo M; Mutoh S
Eur J Pharmacol; 2004 Oct; 501(1-3):137-42. PubMed ID: 15464072
[TBL] [Abstract][Full Text] [Related]
20. Combination of dietary phytosterols plus niacin or fenofibrate: effects on lipid profile and atherosclerosis in apo E-KO mice.
Yeganeh B; Moshtaghi-Kashanian GR; Declercq V; Moghadasian MH
J Nutr Biochem; 2005 Apr; 16(4):222-8. PubMed ID: 15808326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
